Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia

• Conditions: Covid-19

• Registration Number: NCT04362345
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

The aim of the research is to improve patient management by rapidly identifying, based on the terrain and clinical and biological characteristics, those patients likely to present a severe form of ARDS at risk of leading to intensive care

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-04
• Study Start: 2020-04-09
• Study First Submitted: 2020-04-20
• Study First Submitted QC: 2020-04-23
• Study First Posted: 2020-04-24
• Last Update Submitted: 2020-12-24
• Last Update Posted: 2020-12-28
• Primary Completion: 2021-01-09
• Study Completion: 2021-01-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Major patient (≥18 years of age)
• Admitted in March 2020 for confirmed Covid-19 lung disease (nasopharyngeal smear or sputum with SARS-CoV-2 positive PCR).

Exclusion Criteria

• Patient who has expressed opposition to participation in the study.
• Mild forms of infection that do not require hospitalization,
• Subject under safeguard of justice
• Subject under guardianship or trusteeship

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identification of risk factors for severity (death or transfer to resuscitation) of Covid-19 infection	Files analysed retrospectively from March 1st, 2020 to April 15, 2020 will be examined]

Trial Locations

Locations (1)

Service des Maladies Infectieuses et Tropicales; 🇫🇷 Strasbourg, France